Form 4 for OPRX OptimizeRx Corp
Accepted 2023-01-04 00:00:00 ET · period of report 2022-12-30 · accession 0001628280-23-000213 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-04 | 2022-12-30 | OPRX | Vos Ellen O'Connor | Dir | M - OptEx | $0.00 | +409 | 34.1K | +1% | $0 |
| D | 2023-01-04 | 2022-12-30 | OPRX | Vos Ellen O'Connor | Dir | M - OptEx | $0.00 | -409 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-30 | M | A | 409 | $0.00 | 34,133 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Units | 2022-12-30 | M | D | 409 | $0.00 | 0 | D | — · — to — | 409 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) On December 30, 2021 the reporting person was granted 409 restricted stock units which vested in full on December 30, 2022. |